Literature DB >> 3198591

Amino acid sequence of the triple-helical domain of human collagen type VI.

M L Chu1, D Conway, T C Pan, C Baldwin, K Mann, R Deutzmann, R Timpl.   

Abstract

The complete amino acid sequence of the triple-helical domain of human collagen VI was deduced from sequences of appropriate cDNA clones and confirmed to about 50% by Edman degradation of tryptic peptides. This domain consists of three different peptide segments containing some 335-336 amino acid residues originating from central portions of the alpha 1 (VI), alpha 2(VI), and alpha 3(VI) chains, respectively. Sequence identity in the X/Y positions of the Gly-X-Y repeats is rather low (10-15%) between the chains. Peculiar features of these sequences include 3 cysteine residues about 50 (alpha 3(VI)) and 89 (alpha 1(VI), alpha 2(VI)) residues away from the N-terminus and several Gly-X-Y interruptions clustered in the C-terminal two-thirds of the triple helix. These structures are presumably required for cross-linking collagen VI oligomers and for super-coiling of triple helices in the dimers. Other features include 11 Arg-Gly-Asp sequences, some of which are likely to be used as cell-binding sites, and four Asn-X-Thr sequences, allowing N-linked glycosylation along the triple helix. Junctional areas close to the helix contain short, cysteine-rich segments which may seal the triple-helical domain through disulfide bond formation, endowing it with high stability. These features, together with a low sequence homology to fiber-forming and basement-membrane collagens, document the unique character of collagen VI, whose triple helix is specifically adjusted for forming microfibrils in tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198591

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.

Authors:  Leona D Tooley; Laura K Zamurs; Nicola Beecher; Naomi L Baker; Rachel A Peat; Naomi E Adams; John F Bateman; Kathryn N North; Clair Baldock; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

2.  Cloning and chromosomal location of human alpha 1(XVI) collagen.

Authors:  T C Pan; R Z Zhang; M G Mattei; R Timpl; M L Chu
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Molecular composition of type VI collagen. Evidence for chain heterogeneity in mammalian tissues and cultured cells.

Authors:  C M Kielty; R P Boot-Handford; S Ayad; C A Shuttleworth; M E Grant
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

4.  Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy.

Authors:  A Reghan Foley; Ying Hu; Yaqun Zou; Michele Yang; Līvija Medne; Meganne Leach; Laura K Conlin; Nancy Spinner; Tamim H Shaikh; Marni Falk; Ann M Neumeyer; Laurie Bliss; Brian S Tseng; Thomas L Winder; Carsten G Bönnemann
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

5.  Immunolocalisation of type VI collagen in the intervertebral disc.

Authors:  S Roberts; S Ayad; P J Menage
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 6.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

7.  A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Machiko Arita; Sasha Bogdanovich; Sheila M Adams; Sudheer Kumar Gara; Raimund Wagener; Tejvior S Khurana; David E Birk; Mon-Li Chu
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

8.  Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.

Authors:  R Z Zhang; T C Pan; R Timpl; M L Chu
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Dominick G Sudano; Suely K Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

Review 10.  Adipocyte extracellular matrix composition, dynamics and role in obesity.

Authors:  Edwin C M Mariman; Ping Wang
Journal:  Cell Mol Life Sci       Date:  2010-01-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.